Coronary Circulation Responses to Binodenoson, a Selective Adenosine A2A Receptor Agonist

American Journal of Cardiology

Volumn 99, Issue 11, 2007, Pages 1507-1512

  Hodgson, John McB ^a   Dib, Nabil ^b   Kern, Morton J ^c   Bach, Richard G ^d   Barrett, Richard J ^e  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b ARIZONA HEART INSTITUTE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e King Pharmaceuticals Research and Development Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; BINODENOSON;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HYPEREMIA; DISEASE DURATION; DOPPLER FLOW WIRE; DOPPLER FLOWMETER; DRUG INFUSION; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART RATE; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADENOSINE; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY CIRCULATION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RECEPTOR, ADENOSINE A2A; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; VASCULAR RESISTANCE;

EID: 34248655923     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.086     Document Type: Article

References (12)

1. Johnston D.L., Daley J.R., Hodge D.O., Hopfenspirger M.R., and Gibbons R.J. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients. Mayo Clin Proc 70 (1995) 331-336
2. Cerqueira M.D., Verani M.S., Schwaiger M., Heo J., and Iskandrian A.S. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 23 (1994) 384-389
3. Ranhosky A., and Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 81 (1990) 1205-1209
4. 2A adenosine receptor agonist 2-[(cyclohexylmethylene)hydrazine]adenosine (MRE0470) in the rat. Drug Dev Res 42 (1997) 76-85
5. Barrett R.J., Lamson M.J., Johnson J., and Smith W.B. Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers. J Nucl Cardiol 12 (2005) 166-171
6. 2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 19 (2004) 457-464
7. DiSegni E., Higano S.T., Rihal C., Holmes D.R., Lennon R., and Lerman A. Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Catheter Cardiovasc Intervent 54 (2001) 34-40
8. Wilson R.F., Laughlin D.E., Ackell P.H., Chilian W.M., Holida M.D., Hartley C.J., Armstrong M.L., Marcus M.L., and White C.W. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 72 (1985) 82-92
9. Wilson R.F., Wyche K., Christensen B.V., Zimmer S., and Laxson D.D. Effects of adenosine on human coronary arterial circulation. Circulation 82 (1990) 1595-1606
10. Rossen J.D., Quillen J.E., Lopez A.G., Stenberg R.G., Talman C.L., and Winniford M.D. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 18 (1991) 485-491
11. Rossen J.D., Simonetti I., Marcus M.L., and Winniford M.D. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation 79 (1989) 566-572
12. 2A receptor agonists is mediated by direct sympathoexcitation in awake rats. J Pharmacol Exp Ther 316 (2006) 695-7002